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The landmark discovery that adipose tissue expresses
tumor necrosis factor (TNF)- and that the neutraliza-
tion of TNF- leads to the reversal of insulin resistance
totally transformed our view not only of the significance
of adipose tissue but also of the pathogenesis of insulin
resistance (1). Allied with this, the revelation that endo-
thelial nitric oxide (NO) is the major vasodilator (2), that
insulin induces its vasodilatory effect through the induc-
tion of endothelial NO (3) and endothelial nitric oxide
synthase (eNOS) (4), and that TNF- suppresses both
he basal and insulin-induced eNOS expression, NO and
nsulin receptor expression (5) set the stage for the
nderstanding of the abnormal vascular behavior in
nsulin-resistant states of obesity, the metabolic syndrome, and
ype 2 diabetes. Clearly, the pro-inflammatory cytokine
NF- and possibly other cytokines have a key role in the
pathogenesis of both insulin resistance and the related vascular
See pages 232, 238, and 248
abnormalities. The other relevant observations in this respect
are that obesity is characterized by increased oxidative stress,
which reverses caloric restriction and weight loss (6). The
indexes measured in these studies include reactive oxygen
species generation, lipid peroxidation, and protein carbony-
lation. Such changes in obese persons would result in
diminished NO bio-availability, a pro-constrictor state of
the blood vessels, and a potential acceleration of atherogen-
esis. Two other relevant facts need to be stated: caloric
restriction and weight loss result in a fall in plasma TNF-
concentrations in human obese subjects and that the inflam-
matory cytokines generated by the adipose tissue are largely
the contribution of the macrophages in the stromal compo-
nent of the adipose tissue (7,8).
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describing the role of 3 different fat depots: the subcutane-
ous fat, the visceral abdominal fat, and the perivascular fat
around coronary arteries obtained at surgery. Although it is
accepted that the visceral fat is metabolically more active
and that, through its venous drainage, might deliver pro-
inflammatory cytokines directly into the liver and thus
might contribute to the induction of insulin resistance, little
is known about its vascular behavior. One of the 3 articles in
this series describes the functional abnormalities in the
small-sized arteries of the visceral abdominal fat in addition
to demonstrating the increased expression of TNF- and
nicotinamide adenine dinucleotide phosphate oxidase in the
wall of these arteries in patients with severe abdominal
obesity (9). Clearly, therefore, not only does the vessel wall
have a suppression of eNOS and NO generation, there is a
local increase in reactive oxygen species generation that
reduces the bioavailability of whatever NO is produced.
The second article deals with subcutaneous fat in which the
presence of macrophage-containing crown-like structures
(CLS) formed by the accumulation of macrophages around an
apoptotic fat cell is found to be associated with not only an
increase in other inflammatory indexes—including CD68,
CD163, CD8A, leptin, matrix metalloproteinase-9, and
CCL-2—but also an increase in insulin resistance and the
concentration of glucose, triglycerides, low-density lipopro-
tein cholesterol, and C-reactive protein concentrations in-
dependently of the body mass index and waist circumference
(10). In addition, these patients with inflamed adipose tissue
with CLS also have impaired flow-mediated dilation in the
brachial artery. Thus, the authors postulate that there might
be 2 phenotypes within obesity: one with increased inflam-
mation in the adipose tissue, and the other less inflamed.
The former would tend to be more insulin resistant with
abnormal vascular behavior and a greater potential for
atherogenicity, and the latter less so (interestingly, nitrate-
induced vasodilation was significantly diminished in both
CLS positive and negative groups; thus, obesity might be
associated with an impaired response to NO).
The third report in this series deals with the perivascular
fat from epicardial arteries (11). The investigators report
that the ratio of M1 (inflamed and active) to M2 (less
inflamed and more benign) macrophages is related directly
to the expression of pro-inflammatory cytokines, TNF-,
nd CCL-2 and inversely to that of anti-inflammatory
ytokine IL-10. Furthermore, M1/M2 ratio, characterized
y an increase in CD11c/CD206 positive cells is also related
o the severity of atherosclerosis, as measured by the Gensini
core in the coronary arteries. Fat from patients with no
vidence of coronary artery disease did not exhibit such
hanges. In contrast, no such differences were observed in
he subcutaneous fat in association with coronary artery
isease. The question that follows is whether the perivas-
ular fat is affected because it is in close proximity to the
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There is probably 2-way traffic with a significant contribu-
tion of pro-inflammatory cytokines from the adipose tissue
into the arterial wall. There is previous evidence that
inflammatory processes in the adventitia of the artery might
contribute to intramural inflammation, especially in the
media through vasa vasora (12).
Therefore, the adipose tissue in obese subjects is clearly a
generator of pro-inflammatory effects that contribute to
various biological effects in general and also specifically
related to the site at which at which they occur. Thus, the
visceral adipose tissue contributes significantly to hepatic
insulin resistance while that at the subcutaneous site leads to
systemic inflammatory effects. By contrast, the peri-arterial
fat might directly contribute to atherosclerotic inflamma-
tion. The cellular inflammatory changes in the adipose
tissue have to be considered against the background of the
fact that the circulating mononuclear cell, of which the
monocyte is 1 member, in obese subjects is already in a
pro-inflammatory state (13). The monocyte is the precursor
of the macrophage and moves into the adipose tissue
through chemo-attraction induced by CCL-2 from the
adipose tissue (8,14) or into the liver (15), because it is richly
endowed with its receptor, CCR-2. Because insulin sup-
presses both plasma CCL-2 concentrations and the expres-
sion of CCR-2 on mononuclear cells (16), it is likely that, in
insulin resistant states, this system is activated and facilitates
the accumulation of monocyte/macrophages not only in
adipose tissue but also in the atherosclerotic plaque that
generates an abundance of CCL-2.
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